Last week we did a story on Organovo and their sophisticated techniques which allow them to reconstruct breast cancer tissue via 3D printing. Although not ready for market yet, eventually the company aims to sell these breast cancer tissue samples to pharmaceutical companies looking to test drugs to combat this terrible disease.
Organovo, however, isn’t the only company 3D printing cancer cells in a drive to better treat patients. A small company called Nano3D Biosciences, working with Rainbow Coral Corp via a joint venture, has made a breakthrough in regards to breast cancer research using a 3D bioprinting technique.
Nano 3D Biosciences, founded by four Ph.Ds — Glauco R. Souza, David J. Lee, Thomas C. Killian, and Robert M. Raphael — has a mission to turn their magnetic cell culture technology into the industry standard when it comes to bioprinting human tissues.
Using their NanoShuttle technology, within a machine they call the Bio-Assembler, Nano3D is able to create 3-dimensional breast cancer tissue via the manipulation of cells using magnetic nanoparticles. This technology allows for the rapid printing of cells in a tissue-like structure, meaning that animal testing and 2-dimensional cellular testing can be things of the past. The Bio-Assembler works within a common petri-dish or multiwell plate with any cell type. The tissue can then be imaged and studied similarly to that of any other microtissue.
“These results signify a crucial breakthrough in studying cancer cells outside the body and developing new treatments. We at n3D are very proud that the Bio-Assembler, a technology we developed, is being used in critical research such as this important study,” said Dr. Glauco Souza, n3D president and chief science officer.
Rainbow Coral Corp and Nano3D have been working together diligently to create a technique in which large tumor tissues could be fabricated within a short period of time, and that is seemingly what they have accomplished. They have been able to create breast tumors within a 24 hour period measuring 1mm in diameter, control the density and composition of that tumor, and test the efficiencies of common drugs like doxorubicin and Doxil® within that tumor.
“The Bio-Assembler uses biocompatible magnetic nanoparticles to levitate cells, allowing them to grow into 3D structures much faster, easier and more affordably than competing technology currently on the market,” said RBCC CEO Kimberly Palmer. “This cutting-edge study by the team in Texas perfectly shows why the Bio-Assembler is a technology coveted by leading scientists across a variety of disciplines and beautifully illustrates how it’s pushing cellular research forward.”
The hope of researchers is that this technology will enable for much quicker drug testing and discovery, hopefully leading to better treatments of breast cancer. Let’s hear your thoughts on this incredible use of bioprinting within the 3D Printing & Breast Cancer forum thread on 3DPB.com.
You May Also Like
3D Printing for Nerve Regeneration: Gelatin Methacrylate-Based Nerve Guidance Conduits
Chinese researchers delve deeply into tissue engineering, releasing the findings of their recent study in ‘3D printing of gelatin methacrylate-based nerve guidance conduits with multiple channels.’ While there have been...
Aalto University Develops a Novel Bioink for Cardiac Tissue Applications
Finland is one of Europe’s most forested nations. Over 70 percent of the country’s boreal forest is covered with spruce, pine, downy birch, and silver birch. But beyond the splendor...
3D Printing Healthcare Applications for the Elderly
3D printing has many applications in the healthcare industry, as it allows users to fabricate complex, cost-effective, patient-specific devices on-demand. In the same vein, 3D bioprinting is important for applications...
RMMS: The Regenerative Medicine Manufacturing Society Will Target Unmet Needs in 3D Bioprinting
To deal with the challenges in regenerative medicine, in 2018, pioneer bioprinting expert Anthony Atala announced the foundation of an organization dedicated solely to advancing the field through manufacturing. Known...
View our broad assortment of in house and third party products.